Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper
Mark D Mifflin,1 Brent S Betts,1 P Adam Frederick,2 Jason M Feuerman,3 Carlton R Fenzl,4 Majid Moshirfar,1,5 Brian Zaugg1 1Department of Ophthalmology and Visual Sciences, John A Moran Eye Center, University of Utah, Salt Lake City, UT, 2The Eye Center, Huntsville, AL, 3Eye Institute of Austin, Aus...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/0fbc163f2e3c49249d98106a272eb11a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:0fbc163f2e3c49249d98106a272eb11a |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:0fbc163f2e3c49249d98106a272eb11a2021-12-02T05:01:45ZEfficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper1177-5483https://doaj.org/article/0fbc163f2e3c49249d98106a272eb11a2017-06-01T00:00:00Zhttps://www.dovepress.com/efficacy-and-safety-of-a-3-month-loteprednol-etabonate-05-gel-taper-fo-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Mark D Mifflin,1 Brent S Betts,1 P Adam Frederick,2 Jason M Feuerman,3 Carlton R Fenzl,4 Majid Moshirfar,1,5 Brian Zaugg1 1Department of Ophthalmology and Visual Sciences, John A Moran Eye Center, University of Utah, Salt Lake City, UT, 2The Eye Center, Huntsville, AL, 3Eye Institute of Austin, Austin, TX, 4Eye Surgeons Associates, Bettendorf, IA, 5Hoopes Vision, Draper, UT, USA Purpose: To compare the outcome of photorefractive keratectomy (PRK) and complications in patients treated with either loteprednol etabonate 0.5% gel or prednisolone acetate 1% suspension and fluorometholone (fml) 0.1% suspension.Setting: John A Moran Eye Center, University of Utah, Salt Lake City, UT, USA.Design: Prospective, randomized, partially masked trial.Methods: PRK was performed on 261 eyes of 132 participants. Patients were randomized to a postoperative corticosteroid regimen of either loteprednol etabonate 0.5% gel (loteprednol) or prednisolone 1% acetate suspension followed by fluorometholone 0.1% suspension (prednisolone/fml). Primary outcome measures included incidence and grade of postoperative corneal haze and incidence of increased intraocular pressure of 10 mmHg above baseline, or any intraocular pressure over 21 mmHg. Secondary outcome measures included uncorrected distance visual acuity, best corrected distance visual acuity, and manifest refraction spherical equivalent.Results: The incidence of haze in the first 3 months was 2.6% (3/114 eyes) in the loteprednol group and 4.8% (7/147 eyes) in the prednisolone/fml group and was not statistically significant between groups (P=0.37). The incidence of elevated intraocular pressure was 1.8% (2/114 eyes) in the loteprednol group and 4.1% (6/147 eyes) in the prednisolone/fml group, and was not statistically significant between the groups (P=0.12). The mean 3-month postoperative logMAR uncorrected visual acuity was −0.078±0.10 and −0.075±0.09 in the loteprednol and prednisolone/fml groups, respectively (P=0.83).Conclusion: Postoperative corneal haze and elevated intraocular pressure were uncommon in both treatment arms. There was no statistically significant difference between each postoperative regimen. Refractive results were similar and excellent in both treatment arms. A tapered prophylactic regimen of loteprednol 0.5% gel is equally effective to prednisolone 1%/fml 0.1% after PRK. Keywords: PRK, corticosteroid, fluorometholone, loteprednol, lotemax, wavefront optimizedMifflin MDBetts BSFrederick PAFeuerman JMFenzl CRMoshirfar MZaugg BDove Medical PressarticlePRKphotorefractive keratectomyfluorometholoneloteprednollotemaxwavefront optimizedOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 1113-1118 (2017) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
PRK photorefractive keratectomy fluorometholone loteprednol lotemax wavefront optimized Ophthalmology RE1-994 |
| spellingShingle |
PRK photorefractive keratectomy fluorometholone loteprednol lotemax wavefront optimized Ophthalmology RE1-994 Mifflin MD Betts BS Frederick PA Feuerman JM Fenzl CR Moshirfar M Zaugg B Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper |
| description |
Mark D Mifflin,1 Brent S Betts,1 P Adam Frederick,2 Jason M Feuerman,3 Carlton R Fenzl,4 Majid Moshirfar,1,5 Brian Zaugg1 1Department of Ophthalmology and Visual Sciences, John A Moran Eye Center, University of Utah, Salt Lake City, UT, 2The Eye Center, Huntsville, AL, 3Eye Institute of Austin, Austin, TX, 4Eye Surgeons Associates, Bettendorf, IA, 5Hoopes Vision, Draper, UT, USA Purpose: To compare the outcome of photorefractive keratectomy (PRK) and complications in patients treated with either loteprednol etabonate 0.5% gel or prednisolone acetate 1% suspension and fluorometholone (fml) 0.1% suspension.Setting: John A Moran Eye Center, University of Utah, Salt Lake City, UT, USA.Design: Prospective, randomized, partially masked trial.Methods: PRK was performed on 261 eyes of 132 participants. Patients were randomized to a postoperative corticosteroid regimen of either loteprednol etabonate 0.5% gel (loteprednol) or prednisolone 1% acetate suspension followed by fluorometholone 0.1% suspension (prednisolone/fml). Primary outcome measures included incidence and grade of postoperative corneal haze and incidence of increased intraocular pressure of 10 mmHg above baseline, or any intraocular pressure over 21 mmHg. Secondary outcome measures included uncorrected distance visual acuity, best corrected distance visual acuity, and manifest refraction spherical equivalent.Results: The incidence of haze in the first 3 months was 2.6% (3/114 eyes) in the loteprednol group and 4.8% (7/147 eyes) in the prednisolone/fml group and was not statistically significant between groups (P=0.37). The incidence of elevated intraocular pressure was 1.8% (2/114 eyes) in the loteprednol group and 4.1% (6/147 eyes) in the prednisolone/fml group, and was not statistically significant between the groups (P=0.12). The mean 3-month postoperative logMAR uncorrected visual acuity was −0.078±0.10 and −0.075±0.09 in the loteprednol and prednisolone/fml groups, respectively (P=0.83).Conclusion: Postoperative corneal haze and elevated intraocular pressure were uncommon in both treatment arms. There was no statistically significant difference between each postoperative regimen. Refractive results were similar and excellent in both treatment arms. A tapered prophylactic regimen of loteprednol 0.5% gel is equally effective to prednisolone 1%/fml 0.1% after PRK. Keywords: PRK, corticosteroid, fluorometholone, loteprednol, lotemax, wavefront optimized |
| format |
article |
| author |
Mifflin MD Betts BS Frederick PA Feuerman JM Fenzl CR Moshirfar M Zaugg B |
| author_facet |
Mifflin MD Betts BS Frederick PA Feuerman JM Fenzl CR Moshirfar M Zaugg B |
| author_sort |
Mifflin MD |
| title |
Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper |
| title_short |
Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper |
| title_full |
Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper |
| title_fullStr |
Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper |
| title_full_unstemmed |
Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper |
| title_sort |
efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper |
| publisher |
Dove Medical Press |
| publishDate |
2017 |
| url |
https://doaj.org/article/0fbc163f2e3c49249d98106a272eb11a |
| work_keys_str_mv |
AT mifflinmd efficacyandsafetyofa3monthloteprednoletabonate05geltaperforroutineprophylaxisafterphotorefractivekeratectomycomparedtoa3monthprednisoloneacetate1andfluorometholone01taper AT bettsbs efficacyandsafetyofa3monthloteprednoletabonate05geltaperforroutineprophylaxisafterphotorefractivekeratectomycomparedtoa3monthprednisoloneacetate1andfluorometholone01taper AT frederickpa efficacyandsafetyofa3monthloteprednoletabonate05geltaperforroutineprophylaxisafterphotorefractivekeratectomycomparedtoa3monthprednisoloneacetate1andfluorometholone01taper AT feuermanjm efficacyandsafetyofa3monthloteprednoletabonate05geltaperforroutineprophylaxisafterphotorefractivekeratectomycomparedtoa3monthprednisoloneacetate1andfluorometholone01taper AT fenzlcr efficacyandsafetyofa3monthloteprednoletabonate05geltaperforroutineprophylaxisafterphotorefractivekeratectomycomparedtoa3monthprednisoloneacetate1andfluorometholone01taper AT moshirfarm efficacyandsafetyofa3monthloteprednoletabonate05geltaperforroutineprophylaxisafterphotorefractivekeratectomycomparedtoa3monthprednisoloneacetate1andfluorometholone01taper AT zauggb efficacyandsafetyofa3monthloteprednoletabonate05geltaperforroutineprophylaxisafterphotorefractivekeratectomycomparedtoa3monthprednisoloneacetate1andfluorometholone01taper |
| _version_ |
1718400753695981568 |